{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T22:20:43Z","timestamp":1762035643925,"version":"build-2065373602"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T00:00:00Z","timestamp":1615852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T00:00:00Z","timestamp":1615852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s00115-021-01098-w","type":"journal-article","created":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T19:02:26Z","timestamp":1615921346000},"page":"307-316","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Von der Neuromyelitis optica zur Neuromyelitis-optica-Spektrum-Erkrankung: vom klinischen Syndrom zur Klassifikation","From neuromyelitis optica to neuromyelitis optica spectrum disorder: from clinical syndrome to diagnistic classification"],"prefix":"10.1007","volume":"92","author":[{"given":"Orhan","family":"Aktas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tania","family":"K\u00fcmpfel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,16]]},"reference":[{"issue":"12","key":"1098_CR1","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1007\/s00115-018-0550-0","volume":"89","author":"O Aktas","year":"2018","unstructured":"Aktas\u00a0O, Wattjes\u00a0MP, Stangel\u00a0M et al (2018) Diagnose der Multiplen Sklerose: Revision der McDonald-Kriterien 2017 (Diagnosis of multiple sclerosis: revision of the McDonald criteria 2017). Nervenarzt 89(12):1344\u20131354","journal-title":"Nervenarzt"},{"issue":"5","key":"1098_CR2","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1002\/ana.22121","volume":"68","author":"M Apiwattanakul","year":"2010","unstructured":"Apiwattanakul\u00a0M, Popescu\u00a0BF, Matiello\u00a0M et\u00a0al (2010) Intractable vomiting as the initial presentation of neuromyelitis optica. Ann Neurol 68(5):757\u2013761","journal-title":"Ann Neurol"},{"key":"1098_CR3","doi-asserted-by":"publisher","first-page":"778","DOI":"10.3389\/fneur.2020.00778","volume":"11","author":"S Asseyer","year":"2020","unstructured":"Asseyer\u00a0S, Cooper\u00a0G, Paul\u00a0F (2020) Pain in NMOSD and MOGAD: a systematic literature review of pathophysiology, symptoms, and current treatment strategies. Front Neurol 11:778","journal-title":"Front Neurol"},{"issue":"9","key":"1098_CR4","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nrneurol.2014.129","volume":"10","author":"M Bradl","year":"2014","unstructured":"Bradl\u00a0M, Kanamori\u00a0Y, Nakashima\u00a0I et\u00a0al (2014) Pain in neuromyelitis optica\u2014prevalence, pathogenesis and therapy. Nat Rev Neurol 10(9):529\u2013536","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"1098_CR5","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/archneurol.2011.127","volume":"68","author":"N Collongues","year":"2011","unstructured":"Collongues\u00a0N, Cabre\u00a0P, Marignier\u00a0R et\u00a0al (2011) A benign form of neuromyelitis optica: does it exist? Arch Neurol 68(7):918\u2013924","journal-title":"Arch Neurol"},{"issue":"4","key":"1098_CR6","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1177\/1352458512457720","volume":"19","author":"L Elsone","year":"2013","unstructured":"Elsone\u00a0L, Townsend\u00a0T, Mutch\u00a0K et\u00a0al (2013) Neuropathic pruritus (itch) in neuromyelitis optica. Mult Scler 19(4):475\u2013479","journal-title":"Mult Scler"},{"issue":"1","key":"1098_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1159\/000505231","volume":"12","author":"S Fujiwara","year":"2020","unstructured":"Fujiwara\u00a0S, Manabe\u00a0Y, Morihara\u00a0R et al (2020) Two cases of very-late-onset neuromyelitis optica spectrum disorder (NMOSD) in patients over the age of 80. Case Rep Neurol 12(1):13\u201317","journal-title":"Case Rep Neurol"},{"issue":"6","key":"1098_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11940-018-0502-9","volume":"20","author":"GY Gombolay","year":"2018","unstructured":"Gombolay\u00a0GY, Chitnis\u00a0T (2018) Pediatric neuromyelitis optica spectrum disorders. Curr Treat Options Neurol 20(6):19","journal-title":"Curr Treat Options Neurol"},{"issue":"23","key":"1098_CR9","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1212\/WNL.0000000000000489","volume":"82","author":"S Gratton","year":"2014","unstructured":"Gratton\u00a0S, Amjad\u00a0F, Ghavami\u00a0F et\u00a0al (2014) Bilateral hearing loss as a\u00a0manifestation of neuromyelitis optica. Neurology 82(23):2145\u20132146","journal-title":"Neurology"},{"key":"1098_CR10","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3389\/fneur.2020.00501","volume":"11","author":"JY Hor","year":"2020","unstructured":"Hor\u00a0JY, Asgari\u00a0N, Nakashima\u00a0I et\u00a0al (2020) Epidemiology of neuromyelitis optica spectrum disorder and its prevalence and incidence worldwide. Front Neurol 11:501","journal-title":"Front Neurol"},{"issue":"12","key":"1098_CR11","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1007\/s00115-018-0607-0","volume":"89","author":"S Jarius","year":"2018","unstructured":"Jarius\u00a0S, Paul\u00a0F, Aktas\u00a0O et al (2018) MOG-Enzephalomyelitis: Internationale Empfehlungen zu Diagnose und Antik\u00f6rpertestung (MOG encephalomyelitis: international recommendations on diagnosis and antibody testing). Nervenarzt 89(12):1388\u20131399","journal-title":"Nervenarzt"},{"key":"1098_CR12","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12974-016-0717-1","volume":"13","author":"S Jarius","year":"2016","unstructured":"Jarius\u00a0S, Ruprecht\u00a0K, Kleiter\u00a0I et al (2016) MOG-IgG in NMO and related disorders: a\u00a0multicenter study. Part 1: frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin. J\u00a0Neuroinflammation 13:279","journal-title":"J Neuroinflammation"},{"key":"1098_CR13","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12974-016-0718-0","volume":"131","author":"S Jarius","year":"2016","unstructured":"Jarius\u00a0S, Ruprecht\u00a0K, Kleiter\u00a0I et al (2016) MOG-IgG in NMO and related disorders: a\u00a0multicenter study of 50\u00a0patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. J\u00a0Neuroinflammation 131:280","journal-title":"J Neuroinflammation"},{"issue":"8","key":"1098_CR14","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1177\/1352458511431728","volume":"18","author":"S Jarius","year":"2012","unstructured":"Jarius\u00a0S, Paul\u00a0F, Franciotta\u00a0D et al (2012) Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin\u20114 antibody positive cases and a\u00a0review of the literature. Mult Scler 18(8):1135\u20131143","journal-title":"Mult Scler"},{"key":"1098_CR15","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1742-2094-9-14","volume":"9","author":"S Jarius","year":"2012","unstructured":"Jarius\u00a0S, Ruprecht\u00a0K, Wildemann\u00a0B et\u00a0al (2012) Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175\u00a0patients. J\u00a0Neuroinflammation 9:14","journal-title":"J Neuroinflammation"},{"key":"1098_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1742-2094-10-8","volume":"10","author":"S Jarius","year":"2013","unstructured":"Jarius\u00a0S, Wildemann\u00a0B (2013) The history of neuromyelitis optica. J\u00a0Neuroinflammation 10:8","journal-title":"J Neuroinflammation"},{"issue":"1","key":"1098_CR17","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12974-019-1594-1","volume":"16","author":"S Jarius","year":"2019","unstructured":"Jarius\u00a0S, Wildemann\u00a0B (2019) The history of neuromyelitis optica. Part 2: \u2018spinal amaurosis\u2019, or how it all began. J\u00a0Neuroinflammation 16(1):280","journal-title":"J Neuroinflammation"},{"issue":"2","key":"1098_CR18","doi-asserted-by":"publisher","first-page":"e181","DOI":"10.1212\/WNL.0000000000007746","volume":"93","author":"DI Jonsson","year":"2019","unstructured":"Jonsson\u00a0DI, Sveinsson\u00a0O, Hakim\u00a0R et al (2019) Epidemiology of NMOSD in Sweden from 1987 to 2013: a nationwide population-based study. Neurology 93(2):e181\u2013e189","journal-title":"Neurology"},{"issue":"2","key":"1098_CR19","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/ana.24554","volume":"79","author":"I Kleiter","year":"2016","unstructured":"Kleiter\u00a0I, Gahlen\u00a0A, Borisow\u00a0N et\u00a0al (2016) Neuromyelitis optica: evaluation of 871 attacks and 1,153 treatment courses. Ann Neurol 79(2):206\u2013216","journal-title":"Ann Neurol"},{"issue":"5","key":"1098_CR20","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1007\/s00415-015-7766-8","volume":"262","author":"M Krumbholz","year":"2015","unstructured":"Krumbholz\u00a0M, Hofstadt-van Oy\u00a0U, Angstwurm\u00a0K et al (2015) Very late-onset neuromyelitis optica spectrum disorder beyond the age of 75. J\u00a0Neurol 262(5):1379\u20131384","journal-title":"J Neurol"},{"issue":"20","key":"1098_CR21","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1212\/WNL.0b013e31825644ff","volume":"78","author":"MI Leite","year":"2012","unstructured":"Leite\u00a0MI, Coutinho\u00a0E, Lana-Peixoto\u00a0M et al (2012) Myasthenia gravis and neuromyelitis optica spectrum disorder: a\u00a0multicenter study of 16\u00a0patients. Neurology 78(20):1601\u20131607","journal-title":"Neurology"},{"issue":"4","key":"1098_CR22","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1084\/jem.20050304","volume":"202","author":"VA Lennon","year":"2005","unstructured":"Lennon\u00a0VA, Kryzer\u00a0TJ, Pittock\u00a0SJ et al (2005) IgG marker of optic-spinal multiple sclerosis binds to the aquaporin\u20114 water channel. J\u00a0Exp Med 202(4):473\u2013477","journal-title":"J Exp Med"},{"issue":"9451","key":"1098_CR23","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","volume":"364","author":"VA Lennon","year":"2004","unstructured":"Lennon\u00a0VA, Wingerchuk\u00a0DM, Kryzer\u00a0TJ et\u00a0al (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364(9451):2106\u20132112","journal-title":"Lancet"},{"issue":"Pt 7","key":"1098_CR24","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/brain\/awf151","volume":"125","author":"CF Lucchinetti","year":"2002","unstructured":"Lucchinetti\u00a0CF, Mandler\u00a0RN, McGavern\u00a0D et\u00a0al (2002) A role for humoral mechanisms in the pathogenesis of Devic\u2019s neuromyelitis optica. Brain 125(Pt 7):1450\u20131461","journal-title":"Brain"},{"key":"1098_CR25","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.msard.2016.01.006","volume":"6","author":"T Mathew","year":"2016","unstructured":"Mathew\u00a0T, Nadimpally\u00a0US, Sarma\u00a0GRK et\u00a0al (2016) Trigeminal autonomic cephalalgia as a\u00a0presenting feature of neuromyelitis optica: \u201ca rare combination of two uncommon disorders\u201d. Mult Scler Relat Disord 6:73\u201374","journal-title":"Mult Scler Relat Disord"},{"issue":"6","key":"1098_CR26","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1177\/1352458516665497","volume":"23","author":"M Netravathi","year":"2017","unstructured":"Netravathi\u00a0M, Saini\u00a0J, Mahadevan\u00a0A et al (2017) Is pruritus an indicator of aquaporin-positive neuromyelitis optica? Mult Scler 23(6):810\u2013817","journal-title":"Mult Scler"},{"issue":"2","key":"1098_CR27","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41582-018-0112-x","volume":"15","author":"M Reindl","year":"2019","unstructured":"Reindl\u00a0M, Waters\u00a0P (2019) Myelin oligodendrocyte glycoprotein antibodies in neurological disease. Nat Rev Neurol 15(2):89\u2013102","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"1098_CR28","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1177\/1352458513510981","volume":"20","author":"M Ringelstein","year":"2014","unstructured":"Ringelstein\u00a0M, Metz\u00a0I, Ruprecht\u00a0K et al (2014) Contribution of spinal cord biopsy to diagnosis of aquaporin\u20114 antibody positive neuromyelitis optica spectrum disorder. Mult Scler 20(7):882\u2013888","journal-title":"Mult Scler"},{"issue":"Pt 5","key":"1098_CR29","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1093\/brain\/awl371","volume":"130","author":"SF Roemer","year":"2007","unstructured":"Roemer\u00a0SF, Parisi\u00a0JE, Lennon\u00a0VA et al (2007) Pattern-specific loss of aquaporin\u20114 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 130(Pt 5):1194\u20131205","journal-title":"Brain"},{"key":"1098_CR30","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fneur.2016.00073","volume":"7","author":"U Roy","year":"2016","unstructured":"Roy\u00a0U, Saini\u00a0DS, Pan\u00a0K, Pandit\u00a0A, Ganguly\u00a0G, Panwar\u00a0A (2016) Neuromyelitis optica spectrum disorder with tumefactive demyelination mimicking multiple sclerosis: a rare case. Front Neurol 7:73","journal-title":"Front Neurol"},{"issue":"13","key":"1098_CR31","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1177\/1352458516685416","volume":"23","author":"JM Seok","year":"2017","unstructured":"Seok\u00a0JM, Cho\u00a0H\u2011J, Ahn\u00a0S\u2011W et al (2017) Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: a multicenter retrospective study in korea. Mult Scler 23(13):1748\u20131756","journal-title":"Mult Scler"},{"issue":"3","key":"1098_CR32","doi-asserted-by":"publisher","first-page":"e225","DOI":"10.1212\/NXI.0000000000000225","volume":"3","author":"M Sep\u00falveda","year":"2016","unstructured":"Sep\u00falveda\u00a0M, Armangu\u00e9\u00a0T, Sola-Valls\u00a0N et al (2016) Neuromyelitis optica spectrum disorders: comparison according to the phenotype and serostatus. Neurol Neuroimmunol Neuroinflamm 3(3):e225","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"8","key":"1098_CR33","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1136\/jnnp-2017-315603","volume":"88","author":"J-P Stellmann","year":"2017","unstructured":"Stellmann\u00a0J\u2011P, Krumbholz\u00a0M, Friede\u00a0T et al (2017) Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response. J\u00a0Neurol Neurosurg Psychiatry 88(8):639\u2013647","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1098_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2017.04.006","volume":"309","author":"K Suchdev","year":"2017","unstructured":"Suchdev\u00a0K, Razmjou\u00a0S, Venkatachalam\u00a0P et\u00a0al (2017) Late onset neuromyelitis optica mimicking an acute stroke in an elderly patient. J\u00a0Neuroimmunol 309:1\u20133","journal-title":"J Neuroimmunol"},{"issue":"2","key":"1098_CR35","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson\u00a0AJ, Banwell\u00a0BL, Barkhof\u00a0F et\u00a0al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17(2):162\u2013173","journal-title":"Lancet Neurol"},{"issue":"3","key":"1098_CR36","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/ana.24117","volume":"75","author":"MJ Titulaer","year":"2014","unstructured":"Titulaer\u00a0MJ, H\u00f6ftberger\u00a0R, Iizuka\u00a0T et al (2014) Overlapping demyelinating syndromes and anti-N-methyl-D-aspartate receptor encephalitis. Ann Neurol 75(3):411\u2013428","journal-title":"Ann Neurol"},{"issue":"10","key":"1098_CR37","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1007\/s00115-018-0597-y","volume":"89","author":"C Trebst","year":"2018","unstructured":"Trebst\u00a0C, K\u00fcmpfel\u00a0T (2018) Neuroimmunologie und Rheumatologie: Schnittmengen und Differenzialdiagnosen (Neuroimmunology and rheumatology: overlap and differential diagnoses). Nervenarzt 89(10):1095\u20131105","journal-title":"Nervenarzt"},{"issue":"12","key":"1098_CR38","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/nrneurol.2011.176","volume":"7","author":"C Trebst","year":"2011","unstructured":"Trebst\u00a0C, Raab\u00a0P, Voss\u00a0EV et\u00a0al (2011) Longitudinal extensive transverse myelitis\u2014it\u2019s not all neuromyelitis optica. Nat Rev Neurol 7(12):688\u2013698","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"1098_CR39","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S1474-4422(06)70333-7","volume":"5","author":"BG Weinshenker","year":"2006","unstructured":"Weinshenker\u00a0BG, Wingerchuk\u00a0DM, Nakashima\u00a0I et\u00a0al (2006) OSMS is NMO, but not MS: proven clinically and pathologically. Lancet Neurol 5(2):110\u2013111","journal-title":"Lancet Neurol"},{"issue":"2","key":"1098_CR40","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk\u00a0DM, Banwell\u00a0B, Bennett\u00a0JL et\u00a0al (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85(2):177\u2013189","journal-title":"Neurology"},{"issue":"5","key":"1098_CR41","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","volume":"53","author":"DM Wingerchuk","year":"1999","unstructured":"Wingerchuk\u00a0DM, Hogancamp\u00a0WF, O\u2019Brien\u00a0PC et\u00a0al (1999) The clinical course of neuromyelitis optica (Devic\u2019s syndrome). Neurology 53(5):1107\u20131114","journal-title":"Neurology"},{"issue":"9","key":"1098_CR42","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","volume":"6","author":"DM Wingerchuk","year":"2007","unstructured":"Wingerchuk\u00a0DM, Lennon\u00a0VA, Lucchinetti\u00a0CF et\u00a0al (2007) The spectrum of neuromyelitis optica. Lancet Neurol 6(9):805\u2013815","journal-title":"Lancet Neurol"},{"issue":"10","key":"1098_CR43","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","volume":"66","author":"DM Wingerchuk","year":"2006","unstructured":"Wingerchuk\u00a0DM, Lennon\u00a0VA, Pittock\u00a0SJ et\u00a0al (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66(10):1485\u20131489","journal-title":"Neurology"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-021-01098-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00115-021-01098-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-021-01098-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T02:03:14Z","timestamp":1675044194000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00115-021-01098-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,16]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["1098"],"URL":"https:\/\/doi.org\/10.1007\/s00115-021-01098-w","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"type":"print","value":"0028-2804"},{"type":"electronic","value":"1433-0407"}],"subject":[],"published":{"date-parts":[[2021,3,16]]},"assertion":[{"value":"4 February 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"O.\u00a0Aktas erhielt finanzielle Unterst\u00fctzung f\u00fcr Reisen, Vortragst\u00e4tigkeit und\/oder Advisory Boards von Alexion, Bayer Healthcare, Biogen, Teva Pharma, Merck, Novartis, Roche, Sanofi-Aventis\/Genzyme, sowie Unterst\u00fctzung f\u00fcr wissenschaftliche Projekte von Biogen und Novartis. Dies hatte keinen Einfluss auf die vorliegende Arbeit. T.\u00a0K\u00fcmpfel erhielt finanzielle Unterst\u00fctzung f\u00fcr Reisen, Vortragst\u00e4tigkeit und\/oder Advisory boards von Bayer Healthcare, Teva Pharma, Merck, Novartis Pharma, Sanofi-Aventis\/Genzyme, CLB Behring, Roche Pharma and Biogen sowie Unterst\u00fctzung f\u00fcr wissenschaftliche Projekte von Bayer-Schering AG, Novartis and Chugai Pharma. Dies hatte keinen Einfluss auf die vorliegende Arbeit.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}